Energen Corp. Q3 2008 Earnings Conference Call Transcript

Oct. 24, 2008 4:56 AM ETEnergen Corporation (EGN) Stock
SA Transcripts profile picture
SA Transcripts
146.39K Followers

Energen Corp. (EGN) Q3 FY08 Earnings Call October 23, 2008 11:00 AM ET

Executives

Julie S. Ryland - VP IR
James T. McManus, II - Chairman and CEO Energen and all Subsidiaries
Charles W. Porter, Jr. - VP, CFO and Treasurer Energen and all Subsidiaries
John S. Richardson - President and COO

Analysts

Carl Kirst - BMO Capital
Holly Stewart - Howard Weil Incorporated
Crystal Troy - Raymond James

Operator

Good morning. My name is Kevin and I'll be your conference operator today. At this time I would like to welcome everyone to the Energen quarterly earnings conference call. All lines have been placed on mute to prevent any background noise.

After the speakers' remarks there will be a question-and-answer session. [Operator Instructions]

At this time I'd like to turn the call over to Julie Ryland; you may begin your conference.

Julie S. Ryland - Vice President Investor Relations

Thank you, Kevin and good morning to all of you joining Energen Corporation's third quarter earnings conference call. Whether you are joining us by phone or by internet, it's good to have you with us. Today's call is being held in conjunction with our announcement yesterday of the results of operations for the three months ended September 30, 2008.

Our prepared remarks will include statements expressing expectations of future plans, objectives and performance that constitute forward-looking statements made pursuant to the Safe Harbor Provision of the Private Security Litigation Reform Act of 1995.

Except as otherwise disclosed the company's forward-looking statements do not reflect the impact of possible or pending acquisitions, divestitures or restructurings. All statements based on future expectations rather than all historical facts are forward-looking statements. These are dependent on certain events, risks and uncertainties that may be outside the company's control and could cause actual results to differ materially from those anticipated.

Recommended For You

More on EGN-DEFUNCT-216